Acs Pharmacology & Translational Science

Acs Pharmacology & Translational Science

美国药理学与转化科学学会

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Acs Pharmacology & Translational Science》是由American Chemical Society出版社于2018年创办的英文国际期刊(ISSN: 2575-9108),该期刊长期致力于药物化学领域的创新研究,主要研究方向为Multiple。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0496...%),以发表药物化学领域等方向的原创性研究为核心(研究类文章占比83.56%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在164篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Acs Pharmacology & Translational Science该刊近年未被列入国际预警名单,年发文量约164篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 164 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
3区 3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL ESCI Q2 29 / 72

60.4

学科:PHARMACOLOGY & PHARMACY ESCI Q2 109 / 356

69.5

学科:CHEMISTRY, MEDICINAL ESCI Q2 25 / 72

65.97

学科:PHARMACOLOGY & PHARMACY ESCI Q2 98 / 356

72.61

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL ESCI Q1 13 / 72

82.6

学科:PHARMACOLOGY & PHARMACY ESCI Q1 45 / 354

87.4

学科:CHEMISTRY, MEDICINAL ESCI Q1 7 / 72

90.97

学科:PHARMACOLOGY & PHARMACY ESCI Q1 30 / 354

91.67

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.1 SJR:1.673 SNIP:0.916
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q2 75 / 255

70%

大类:Medicine 小类:Pharmacology Q2 128 / 303

57%

期刊发文

  • T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therap

    Author: Chen, Wenlong; Zhang, Zining; Zhao, Chuangchuang; Wang, Bo; Liao, Xiang; Li, Qinghua; Wang, Dongqing; Fu, Shengxiang; Tsai, Hsiang-i

    Journal: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 2026; Vol. 9, Issue 4, pp. 1010-1020. DOI: 10.1021/acsptsci.6c00065

  • A Paradigm Shift in Snakebite Envenoming Therapy: From Conventional Antivenoms to Rationally Designed, Broadly Neutralizing Combination Therapie

    Author: Shi, Ning; Wang, Jie; Xu, Can; Jiang, Xingjun; Ren, Caiping; Gao, Xiang; Luo, Longlong

    Journal: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsptsci.6c00130

  • Cathepsin B-Responsive Phosphatidylinositol 3-Kinase (PI3K) Prodrug for the Treatment of Pulmonary Fibrosi

    Author: Li, Xiaomei; Yang, Tao; Lei, Shuyue; Jiang, Xing; Zhu, Shulei; Li, Xuzhuo; Ding, Mengyuan; Tang, Wei; Lu, Wei

    Journal: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsptsci.5c00728

  • Schisandrin B Upregulates Sirtuin 3 and Mitigates Lung Epithelial Injury Induced by Nickel Nanoparticle

    Author: Zhang, Bo; Xing, Yue-Chen; Tang, Ge-Ge; Wu, Rui-Ze; Jin, Shuo; Sun, Qian-Qian; Li, Ji-Ping; Yu, Su-An; Liu, Wei-Yang; Wang, Yue; Wu, Yong-Hui

    Journal: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsptsci.6c00010

  • Mitochondria-Targeted Titanium Complex Exerts Potent Anticancer Activity by Disturbing Iron Homeostasi

    Author: Guan, Qi-Xin; Yu, Long-Bo; Wang, Peng; Hu, Qing-yuan; Tan, Cai-Ping

    Journal: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 2025; Vol. 8, Issue 6, pp. 1804-1813. DOI: 10.1021/acsptsci.5c00219

  • Development of Novel 99mTc-Labeled Hydrazinoicotinamide-Modified Ubiquicidin 29-41 Complexes with Improved Target-to-Nontarget Ratios for Bacterial Infection Imagin

    Author: Jiang, Yuhao; Wang, Qianna; Yin, Guangxing; Feng, Junhong; Ruan, Qing; Han, Peiwen; Zhang, Junbo

    Journal: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 2025; Vol. 8, Issue 2, pp. 470-483. DOI: 10.1021/acsptsci.4c00599

  • Alcohol Consumption Modulates the Development of Chronic Pain in COVID-19 Patients: A Network Meta-Analysi

    Author: Bishir, Muhammed; Vigorito, Michael; Chan, Ming-Huan; Khan, Mohammed A. S.; Chang, Sulie L.

    Journal: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 2025; Vol. 8, Issue 2, pp. 409-422. DOI: 10.1021/acsptsci.4c00479

  • Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling for Iron-Regulated Hematopoietic Stem and Progenitor Cells' Commitment toward Erythroid and Megakaryocytic Lineage

    Author: Cao, Kangna; Fan, Xiaoqing; Wong, Raymond S. M.; Yan, Xiaoyu

    Journal: ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 2025; Vol. , Issue , pp. -. DOI: 10.1021/acsptsci.5c00097